Industrial Synthesis Route 2-Chloro-4-(Piperidin-1-Ylmethyl)Pyridine Manufacturing Process
- [Reaction Kinetics]: Optimized three-step pathway achieving over 32% overall yield from 2-amino-4-picoline.
- [Logistics Capacity]: Secure tonnage quantities available with factory-direct stability and verified documentation.
- [Compliance Framework]: Adherence to strict quality parameters ensuring suitability for pharmaceutical intermediate applications.
The demand for high-efficiency pharmaceutical intermediate production is driven by the need to reduce costs in complex drug synthesis, particularly for anti-ulcer medications like Lafutidine. Historically, traditional methods required cumbersome five-step reactions, resulting in elevated operational expenses and lower throughput. Modern process chemistry has shifted towards a streamlined three-step synthesis route that maximizes atom economy while maintaining rigorous quality standards. This technical overview details the manufacturing process for C11H15ClN2, focusing on reaction conditions, yield optimization, and supply chain reliability for bulk procurement.
Optimized Chemical Pathway and Reaction Yields
For process chemists and R&D teams, the integrity of the synthetic pathway is paramount. The preferred industrial method utilizes 2-amino-4-picoline as the starting raw material. This approach eliminates unnecessary halogenation steps found in legacy protocols, directly addressing impurity profiles that comp downstream purification.
Step 1: Diazotization and Chlorination
The initial phase involves the conversion of 2-amino-4-picoline into 2-chloro-4-picoline. Under cryosel bath freezing conditions, the amine undergoes diazotization using nitrite aqueous solutions (Sodium Nitrite or Potassium Nitrite) in the presence of strong acids such as sulfuric or hydrochloric acid. Following hydrolysis and extraction, the intermediate is treated with phosphorus oxychloride (POCl3). Refluxing at 80-110°C ensures complete conversion. Data from pilot scales indicate this step consistently achieves yields exceeding 88%, providing a robust foundation for subsequent reactions.
Step 2: Radical Chloromethylation
The second stage introduces the chloromethyl group essential for the final coupling. Using carbon tetrachloride or similar solvents, 2-chloro-4-picoline reacts with sulfuryl dichloride (SO2Cl2). Critical to this step is the controlled addition of radical initiators such as AIBN or benzoyl peroxide. Maintaining temperatures around 80°C and managing exothermic profiles are vital for safety and selectivity. This radical substitution typically proceeds with a yield of approximately 77%, generating 2-chloro-4-chloromethylpyridine with minimal dichloro impurities.
Step 3: Nucleophilic Condensation
The final coupling reaction condenses the chloromethyl intermediate with piperidine. Using DMF as the solvent and potassium carbonate as an acid-binding agent, the reaction is refluxed at 80°C. This nucleophilic substitution is highly efficient, often reaching yields of 92%. The result is a light yellow oily liquid that, upon proper workup and drying, meets industrial purity specifications required for sensitive downstream API synthesis.
Technical Specifications and Quality Parameters
To ensure batch-to-batch consistency for large-scale production, manufacturers must adhere to strict technical specifications. The following table outlines the standard quality parameters expected for commercial grade supply.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 146270-01-1 | Verified |
| Chemical Formula | C11H15ClN2 | Elemental Analysis |
| Purity (GC/HPLC) | > 98.5% | Internal QC |
| Appearance | Light Yellow to Colorless Liquid | Visual |
| Water Content | < 0.5% | Karl Fischer |
| Packaging | 25kg / 200kg Drums | Standard |
Procurement Stability and Bulk Supply Chain
For procurement officers, supply chain resilience is as critical as chemical quality. Sourcing this heterocyclic compound from a established global manufacturer mitigates the risk of production bottlenecks. Legacy suppliers often struggle with the handling of corrosive reagents like POCl3 and SO2Cl2, leading to inconsistent availability. In contrast, optimized facilities manage these hazards through dedicated waste management systems and automated dosing, ensuring uninterrupted factory supply.
When evaluating vendors, buyers should prioritize partners who offer transparent documentation. A comprehensive Certificate of Analysis (COA) and Safety Data Sheet (SDS) are non-negotiable for regulatory audits. Furthermore, securing a competitive bulk price often depends on the supplier's ability to synthesize the material in-house rather than trading packaged goods. NINGBO INNO PHARMCHEM CO.,LTD. operates as a premier global manufacturer offering these technical advantages and bulk supply, ensuring that clients receive factory-direct pricing without intermediary markups.
Commercial Viability and Regulatory Compliance
Executive decision-makers must weigh the commercial viability of any intermediate against regulatory hurdles. The streamlined three-step process significantly reduces the environmental footprint compared to traditional five-step methods, lowering waste disposal costs and enhancing sustainability metrics. This efficiency translates directly to reduced COGS (Cost of Goods Sold) for the final API.
Compliance with international standards such as REACH and TSCA is essential for market access in Europe and North America. Robust manufacturing processes ensure that impurity profiles remain within acceptable limits, facilitating smoother regulatory filings. For teams sourcing high-purity 2-Chloro-4-(piperidin-1-ylmethyl)pyridine, verifying the manufacturer's compliance history is a key due diligence step.
Conclusion and Technical Support
The evolution of the manufacturing process for this key Lafutidine intermediate demonstrates the importance of integrating chemical efficiency with supply chain reliability. By adopting the optimized three-step synthesis route, producers can achieve higher yields and lower costs while maintaining the strict purity required for pharmaceutical applications.
To secure supply for your upcoming production cycles, we recommend contacting our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Partnering with a knowledgeable supplier ensures that your synthesis pipeline remains efficient, compliant, and cost-effective.